Berge A. Minassian

17.0k total citations
182 papers, 6.8k citations indexed

About

Berge A. Minassian is a scholar working on Genetics, Rheumatology and Molecular Biology. According to data from OpenAlex, Berge A. Minassian has authored 182 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Genetics, 108 papers in Rheumatology and 67 papers in Molecular Biology. Recurrent topics in Berge A. Minassian's work include Glycogen Storage Diseases and Myoclonus (108 papers), Genetics and Neurodevelopmental Disorders (101 papers) and Lysosomal Storage Disorders Research (41 papers). Berge A. Minassian is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (108 papers), Genetics and Neurodevelopmental Disorders (101 papers) and Lysosomal Storage Disorders Research (41 papers). Berge A. Minassian collaborates with scholars based in Canada, United States and Italy. Berge A. Minassian's co-authors include Julie Turnbull, Stephen W. Scherer, Antonio V. Delgado‐Escueta, Cameron Ackerley, Xiaochu Zhao, Hannes Lohi, Leonarda Ianzano, Elayne M. Chan, Pasquale Striano and Felix Nitschké and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Berge A. Minassian

177 papers receiving 6.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berge A. Minassian Canada 45 3.5k 3.1k 2.5k 1.6k 1.3k 182 6.8k
Krystyna E. Wisniewski United States 35 1.2k 0.3× 345 0.1× 2.0k 0.8× 2.1k 1.3× 180 0.1× 104 4.8k
E. Andermann Canada 38 985 0.3× 418 0.1× 1.3k 0.5× 472 0.3× 467 0.4× 105 4.4k
Christian Kubisch Germany 37 971 0.3× 237 0.1× 4.6k 1.8× 739 0.5× 1.1k 0.8× 144 7.3k
Patrick A. Dion Canada 42 680 0.2× 175 0.1× 3.0k 1.2× 803 0.5× 3.9k 2.9× 180 6.9k
Peter De Jonghe Belgium 59 2.3k 0.7× 209 0.1× 5.4k 2.2× 976 0.6× 2.5k 1.9× 235 13.0k
Manfred W. Kilimann Germany 38 738 0.2× 676 0.2× 2.2k 0.9× 546 0.3× 367 0.3× 95 4.1k
Jonathan L. Haines United States 35 1.7k 0.5× 181 0.1× 1.6k 0.6× 328 0.2× 314 0.2× 66 4.2k
Leanne M. Dibbens Australia 38 2.1k 0.6× 202 0.1× 2.2k 0.9× 248 0.2× 267 0.2× 73 4.9k
Yan Shen China 35 706 0.2× 266 0.1× 2.1k 0.8× 366 0.2× 249 0.2× 109 4.2k
J. Raphael Gibbs United States 35 1.3k 0.4× 96 0.0× 2.4k 0.9× 882 0.6× 1.4k 1.1× 83 4.6k

Countries citing papers authored by Berge A. Minassian

Since Specialization
Citations

This map shows the geographic impact of Berge A. Minassian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berge A. Minassian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berge A. Minassian more than expected).

Fields of papers citing papers by Berge A. Minassian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berge A. Minassian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berge A. Minassian. The network helps show where Berge A. Minassian may publish in the future.

Co-authorship network of co-authors of Berge A. Minassian

This figure shows the co-authorship network connecting the top 25 collaborators of Berge A. Minassian. A scholar is included among the top collaborators of Berge A. Minassian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berge A. Minassian. Berge A. Minassian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanz, Pascual, José M. Serratosa, Jordi Durán, et al.. (2025). The 9th annual Lafora science symposium: a rare epilepsy community makes progress towards clinical readiness. Epilepsy & Behavior. 171. 110654–110654.
2.
Dowling, James J., Mustafa Şahin, Darius Ebrahimi‐Fakhari, et al.. (2024). AAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient. Nature Medicine. 30(7). 1882–1887. 11 indexed citations
3.
Krishnan, Vaishnav, Arindam Ghosh Mazumder, Sam Lee, et al.. (2024). Clinicopathologic Dissociation: Robust Lafora Body Accumulation in Malin KO Mice Without Observable Changes in Home‐Cage Behavior. The Journal of Comparative Neurology. 532(7). e25660–e25660.
4.
Minassian, Berge A., et al.. (2024). Progressive Myoclonus Epilepsy: A Scoping Review of Diagnostic, Phenotypic and Therapeutic Advances. Genes. 15(2). 171–171. 8 indexed citations
5.
Chan, Kimberly L., et al.. (2024). 1H and 31P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora disease. Brain Communications. 6(2). fcae104–fcae104. 1 indexed citations
6.
Minassian, Berge A., et al.. (2024). SURF1 Deficiency: Expanding on Disease Phenotype and Assessing Disease Burden by Describing Clinical and Biochemical Phenotype. American Journal of Medical Genetics Part A. 197(4). e63947–e63947. 3 indexed citations
7.
Fitzsimmons, Bethany, Ronald C. Bruntz, Kia H. Markussen, et al.. (2023). Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model. Neurotherapeutics. 20(6). 1808–1819. 11 indexed citations
8.
Vincent, Ajoy, et al.. (2023). Retinal Phenotyping of a Murine Model of Lafora Disease. Genes. 14(4). 854–854.
9.
Ahonen, Saija, Silvia Nitschke, Tamar R. Grossman, et al.. (2021). Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease. Brain. 144(10). 2985–2993. 40 indexed citations
10.
Nitschke, Silvia, Xiaochu Zhao, Ami M. Perri, et al.. (2020). An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice. Journal of Biological Chemistry. 296. 100150–100150. 18 indexed citations
11.
Linderman, Rachel E., Phyllis Summerfelt, Toco Yuen Ping Chui, et al.. (2020). Retinal manifestations of Lafora disease. Investigative Ophthalmology & Visual Science. 61(7). 5037–5037. 1 indexed citations
12.
Jiang, Xiao, Nazzareno D’Avanzo, Mathieu Lachance, et al.. (2019). Both gain‐of‐function and loss‐of‐function de novo CACNA 1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox‐Gastaut syndrome. Epilepsia. 60(9). 1881–1894. 62 indexed citations
13.
Niibori, Yosuke, et al.. (2019). Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome. Human Gene Therapy. 31(5-6). 339–351. 51 indexed citations
14.
Nita, Dragos A., Sara Mole, & Berge A. Minassian. (2016). Neuronal ceroid lipofuscinoses. Epileptic Disorders. 18(s2). 73–88. 106 indexed citations
15.
Turnbull, Julie, Pasquale Striano, Pierre Genton, et al.. (2016). Lafora disease. Epileptic Disorders. 18(s2). 38–62. 104 indexed citations
16.
17.
Turnbull, Julie, Hannes Lohi, Elayne M. Chan, et al.. (2012). Early-onset Lafora body disease. Brain. 135(9). 2684–2698. 55 indexed citations
18.
Chan, Elayne M., Danielle M. Andrade, Silvana Franceschetti, & Berge A. Minassian. (2005). Progressive myoclonus epilepsies: EPM1, EPM2A, EPM2B.. PubMed. 95. 47–57. 26 indexed citations
19.
Turnbull, Julie, Hannes Lohi, Jennifer A. Kearney, et al.. (2005). Sacred disease secrets revealed: the genetics of human epilepsy. Human Molecular Genetics. 14(17). 2491–2500. 63 indexed citations
20.
Minassian, Berge A., Timothy M. DeLorey, Richard W. Olsen, et al.. (1998). THE EEG OF EPILEPSY PHENOTYPES IN ANGELMAN SYNDROME CHROMOSOME 15Q11-13 DELETIONS, UNIPARENTAL DISOMY, METHYLATION IMPRINT ABNORMALITIES, AND UBE3A MUTATION. Journal of Clinical Neurophysiology. 15(3). 275–275. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Krystyna E. Wisniewski Breakdown of academic impact, for papers by E. Andermann Breakdown of academic impact, for papers by Christian Kubisch Breakdown of academic impact, for papers by Patrick A. Dion Breakdown of academic impact, for papers by Peter De Jonghe Breakdown of academic impact, for papers by Manfred W. Kilimann Breakdown of academic impact, for papers by Jonathan L. Haines Breakdown of academic impact, for papers by Leanne M. Dibbens Breakdown of academic impact, for papers by Yan Shen Breakdown of academic impact, for papers by J. Raphael Gibbs
Rankless by CCL
2026